• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新冠病毒JN.1逃逸株通过靶向两个细胞毒性T细胞表位热点实现T细胞免疫逃逸

T cell immune evasion by SARS-CoV-2 JN.1 escapees targeting two cytotoxic T cell epitope hotspots.

作者信息

Tian Jinmin, Shang Bingli, Zhang Jianing, Guo Yuanyuan, Li Min, Hu Yuechao, Bai Dan, She Junying, Han Yang, Guo Peipei, Huang Mengkun, Wang Yalan, Liu Maoshun, Zhang Jie, Ye Beiwei, Guo Yaxin, Yang Mengjie, Lin Ying, Zhang Ting, Sun Xin, Yuan Xiaoju, Zhang Danni, Xu Ziqian, Chai Yan, Qi Jianxun, Liu Kefang, Tan Shuguang, Zhao Yingze, Zhou Jikun, Song Rui, Gao George F, Liu Jun

机构信息

National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases (NITFID), National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.

NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.

出版信息

Nat Immunol. 2025 Feb;26(2):265-278. doi: 10.1038/s41590-024-02051-0. Epub 2025 Jan 28.

DOI:10.1038/s41590-024-02051-0
PMID:39875585
Abstract

Although antibody escape is observed in emerging severe acute respiratory syndrome coronavirus 2 variants, T cell escape, especially after the global circulation of BA.2.86/JN.1, is unexplored. Here we demonstrate that T cell evasion exists in epitope hotspots spanning BA.2.86/JN.1 mutations. The newly emerging Q229K at this conserved nucleocapsid protein site impairs HLA-A2 epitope hotspot recognition. The association between HLA-A24 convalescents and T cell immune escape points to the spike (S) protein epitope SNYNYLYRLF, with multiple mutations from Delta to JN.1, including L452Q, L452R, F456L, N450D and L452W, and N450D, L452W and L455S. A cliff drop of immune responses was observed for SNYNYRYRLF (Delta/BA.5.2) and SNYDYWYRSF (JN.1), but with immune preservation of SNYDYWYRLF (BA.2.86). Structural analyses showed that hydrophobicity exposure determines the pronounced escape of L452R and L455S mutants, which was further confirmed by T cell receptor binding. This study highlights the characteristics and molecular mechanisms of the T cell immune escape for JN.1 and provides new insights into understanding the dominant circulation of variants, from the viewpoint of cytotoxic T cell evasion.

摘要

尽管在新出现的严重急性呼吸综合征冠状病毒2变种中观察到了抗体逃逸现象,但T细胞逃逸,尤其是在BA.2.86/JN.1全球传播之后,尚未得到研究。在此,我们证明在跨越BA.2.86/JN.1突变的表位热点中存在T细胞逃逸。在这个保守的核衣壳蛋白位点新出现的Q229K损害了HLA - A2表位热点识别。HLA - A24康复者与T细胞免疫逃逸之间的关联指向刺突(S)蛋白表位SNYNYLYRLF,从德尔塔毒株到JN.1有多个突变,包括L452Q、L452R、F456L、N450D和L452W,以及N450D、L452W和L455S。观察到针对SNYNYRYRLF(德尔塔/BA.5.2)和SNYDYWYRSF(JN.1)的免疫反应急剧下降,但SNYDYWYRLF(BA.2.86)的免疫反应得以保留。结构分析表明,疏水性暴露决定了L452R和L455S突变体的显著逃逸,这通过T细胞受体结合得到了进一步证实。本研究突出了JN.1的T细胞免疫逃逸特征和分子机制,并从细胞毒性T细胞逃逸的角度为理解变种的优势传播提供了新见解。

相似文献

1
T cell immune evasion by SARS-CoV-2 JN.1 escapees targeting two cytotoxic T cell epitope hotspots.新冠病毒JN.1逃逸株通过靶向两个细胞毒性T细胞表位热点实现T细胞免疫逃逸
Nat Immunol. 2025 Feb;26(2):265-278. doi: 10.1038/s41590-024-02051-0. Epub 2025 Jan 28.
2
AlphaFold2 Modeling and Molecular Dynamics Simulations of the Conformational Ensembles for the SARS-CoV-2 Spike Omicron JN.1, KP.2 and KP.3 Variants: Mutational Profiling of Binding Energetics Reveals Epistatic Drivers of the ACE2 Affinity and Escape Hotspots of Antibody Resistance.AlphaFold2 对 SARS-CoV-2 刺突奥密克戎 JN.1、KP.2 和 KP.3 变体构象集合的建模和分子动力学模拟:结合能突变分析揭示 ACE2 亲和力的上位驱动因素和抗体耐药性逃逸热点。
Viruses. 2024 Sep 13;16(9):1458. doi: 10.3390/v16091458.
3
Structural insights into immune escape at killer T cell epitope by SARS-CoV-2 Spike Y453F variants.结构洞察 SARS-CoV-2 刺突 Y453F 变异体在杀伤性 T 细胞表位的免疫逃逸。
J Biol Chem. 2024 Aug;300(8):107563. doi: 10.1016/j.jbc.2024.107563. Epub 2024 Jul 11.
4
CD8 T-Cell Epitope Variations Suggest a Potential Antigen HLA-A2 Binding Deficiency for Spike Protein of SARS-CoV-2.CD8 T 细胞表位变异提示 SARS-CoV-2 刺突蛋白潜在的抗原 HLA-A2 结合缺陷。
Front Immunol. 2022 Jan 18;12:764949. doi: 10.3389/fimmu.2021.764949. eCollection 2021.
5
Role of glycosylation mutations at the N-terminal domain of SARS-CoV-2 XEC variant in immune evasion, cell-cell fusion, and spike stability.新型冠状病毒XEC变异株N端结构域糖基化突变在免疫逃逸、细胞间融合及刺突蛋白稳定性中的作用
J Virol. 2025 Apr 15;99(4):e0024225. doi: 10.1128/jvi.00242-25. Epub 2025 Mar 26.
6
Comparative analysis of replication and immune evasion among SARS-CoV-2 subvariants BA.2.86, JN.1, KP.2, and KP.3.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)亚型BA.2.86、JN.1、KP.2和KP.3的复制与免疫逃逸比较分析
mBio. 2025 Apr 29:e0350324. doi: 10.1128/mbio.03503-24.
7
Lineage-specific pathogenicity, immune evasion, and virological features of SARS-CoV-2 BA.2.86/JN.1 and EG.5.1/HK.3.SARS-CoV-2 BA.2.86/JN.1 和 EG.5.1/HK.3 的谱系特异性致病性、免疫逃逸和病毒学特征。
Nat Commun. 2024 Oct 9;15(1):8728. doi: 10.1038/s41467-024-53033-7.
8
Structural basis for the evolution and antibody evasion of SARS-CoV-2 BA.2.86 and JN.1 subvariants.SARS-CoV-2 BA.2.86 和 JN.1 亚变种的进化和抗体逃逸的结构基础。
Nat Commun. 2024 Sep 4;15(1):7715. doi: 10.1038/s41467-024-51973-8.
9
Distinct patterns of SARS-CoV-2 BA.2.87.1 and JN.1 variants in immune evasion, antigenicity, and cell-cell fusion.SARS-CoV-2 BA.2.87.1 和 JN.1 变体在免疫逃逸、抗原性和细胞间融合方面的独特模式。
mBio. 2024 May 8;15(5):e0075124. doi: 10.1128/mbio.00751-24. Epub 2024 Apr 9.
10
Characterizing HLA-A2-restricted CD8 T-cell epitopes and immune responses to Omicron variants in SARS-CoV-2-inactivated vaccine recipients.鉴定新冠病毒灭活疫苗接种者中HLA-A2限制性CD8 T细胞表位及对奥密克戎变异株的免疫反应
Front Immunol. 2025 Mar 18;16:1534530. doi: 10.3389/fimmu.2025.1534530. eCollection 2025.

引用本文的文献

1
T cell epitope mapping reveals immunodominance of evolutionarily conserved regions within SARS-CoV-2 proteome.T细胞表位图谱分析揭示了严重急性呼吸综合征冠状病毒2(SARS-CoV-2)蛋白质组中进化保守区域的免疫显性。
iScience. 2025 Jul 2;28(8):113044. doi: 10.1016/j.isci.2025.113044. eCollection 2025 Aug 15.
2
MHC-I pathway disruption by viruses: insights into immune evasion and vaccine design for animals.病毒对MHC-I途径的破坏:对动物免疫逃避和疫苗设计的见解
Front Immunol. 2025 May 8;16:1540159. doi: 10.3389/fimmu.2025.1540159. eCollection 2025.
3
Unravelling the interplay between respiratory disease and the immune landscape in long COVID.

本文引用的文献

1
Structural insights into immune escape at killer T cell epitope by SARS-CoV-2 Spike Y453F variants.结构洞察 SARS-CoV-2 刺突 Y453F 变异体在杀伤性 T 细胞表位的免疫逃逸。
J Biol Chem. 2024 Aug;300(8):107563. doi: 10.1016/j.jbc.2024.107563. Epub 2024 Jul 11.
2
Nonconserved epitopes dominate reverse preexisting T cell immunity in COVID-19 convalescents.非保守表位主导 COVID-19 恢复期患者的反向预先存在 T 细胞免疫。
Signal Transduct Target Ther. 2024 Jun 12;9(1):160. doi: 10.1038/s41392-024-01876-3.
3
Neutralization of EG.5, EG.5.1, BA.2.86, and JN.1 by antisera from dimeric receptor-binding domain subunit vaccines and 41 human monoclonal antibodies.
揭示长期新冠中呼吸系统疾病与免疫格局之间的相互作用。
Nat Immunol. 2025 May;26(5):640-641. doi: 10.1038/s41590-025-02140-8.
4
Conformational and Stability Analysis of SARS-CoV-2 Spike Protein Variants by Molecular Simulation.通过分子模拟对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白变体进行构象和稳定性分析。
Pathogens. 2025 Mar 12;14(3):274. doi: 10.3390/pathogens14030274.
二聚体受体结合域亚单位疫苗和 41 个人源单克隆抗体对 EG.5、EG.5.1、BA.2.86 和 JN.1 的中和作用。
Med. 2024 May 10;5(5):401-413.e4. doi: 10.1016/j.medj.2024.03.006. Epub 2024 Apr 3.
4
The omicron BA.2.86 subvariant as a new serotype of SARS-CoV-2.作为严重急性呼吸综合征冠状病毒2(SARS-CoV-2)新血清型的奥密克戎BA.2.86亚变体
Lancet Microbe. 2024 Jun;5(6):e516. doi: 10.1016/S2666-5247(23)00411-1. Epub 2024 Feb 7.
5
Memory T cells effectively recognize the SARS-CoV-2 hypermutated BA.2.86 variant.记忆T细胞能有效识别严重急性呼吸综合征冠状病毒2(SARS-CoV-2)高度变异的BA.2.86变体。
Cell Host Microbe. 2024 Feb 14;32(2):156-161.e3. doi: 10.1016/j.chom.2023.12.010. Epub 2024 Jan 10.
6
Post-pandemic memory T cell response to SARS-CoV-2 is durable, broadly targeted, and cross-reactive to the hypermutated BA.2.86 variant.大流行后针对 SARS-CoV-2 的记忆 T 细胞反应具有持久性、广泛靶向性和对高度突变的 BA.2.86 变体的交叉反应性。
Cell Host Microbe. 2024 Feb 14;32(2):162-169.e3. doi: 10.1016/j.chom.2023.12.003. Epub 2024 Jan 10.
7
Immune evasion, infectivity, and fusogenicity of SARS-CoV-2 BA.2.86 and FLip variants.新型冠状病毒SARS-CoV-2 BA.2.86和FLip变体的免疫逃逸、传染性和融合性
Cell. 2024 Feb 1;187(3):585-595.e6. doi: 10.1016/j.cell.2023.12.026. Epub 2024 Jan 8.
8
SARS-CoV-2 BA.2.86 enters lung cells and evades neutralizing antibodies with high efficiency.SARS-CoV-2 BA.2.86 高效进入肺部细胞并逃避中和抗体。
Cell. 2024 Feb 1;187(3):596-608.e17. doi: 10.1016/j.cell.2023.12.025. Epub 2024 Jan 8.
9
Fusogenicity of SARS-CoV-2 BA.2.86 subvariant and its sensitivity to the prokaryotic recombinant EK1 peptide.严重急性呼吸综合征冠状病毒2型BA.2.86亚变体的融合性及其对原核重组EK1肽的敏感性。
Cell Discov. 2024 Jan 9;10(1):6. doi: 10.1038/s41421-023-00631-2.
10
Long-lasting humoral and cellular memory immunity to vaccinia virus Tiantan provides pre-existing immunity against mpox virus in Chinese population.中国人群对天坛痘苗病毒持久的体液和细胞记忆免疫为应对猴痘病毒提供了预先存在的免疫力。
Cell Rep. 2024 Jan 23;43(1):113609. doi: 10.1016/j.celrep.2023.113609. Epub 2023 Dec 29.